Lack of effect of oral cabotegravir on the pharmacokinetics of a levonorgestrel/ethinyl oestradiol‐containing oral contraceptive in healthy adult women

AIMS: This study aimed to investigate whether cabotegravir (CAB), an integrase inhibitor in development for treatment and prevention of human immunodeficiency virus‐1, influences the pharmacokinetics (PK) of a levonorgestrel (LNG) and ethinyl oestradiol (EO)–containing oral contraceptive (OC) in hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Trezza, Christine, Ford, Susan L., Gould, Elizabeth, Lou, Yu, Huang, Chuyun, Ritter, James M., Buchanan, Ann M., Spreen, William, Patel, Parul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Drug Interactions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465324/
https://www.ncbi.nlm.nih.gov/pubmed/28087972
http://dx.doi.org/10.1111/bcp.13236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465324/
https://www.ncbi.nlm.nih.gov/pubmed/28087972
http://dx.doi.org/10.1111/bcp.13236

Ejemplares similares